Press "Enter" to skip to content

New patent for Allergan Holdings drug VIBERZI

0
Copyright © DrugPatentWatch. Originally published at New patent for Allergan Holdings drug VIBERZI

Annual Drug Patent Expirations for VIBERZI
Annual Drug Patent Expirations for VIBERZI

Viberzi is a drug marketed by Allergan Holdings and is included in one NDA. It is available from one supplier. There are fourteen patents protecting this drug.

VIBERZI drug price trends.

Drug patent litigation for VIBERZI.

This drug has one hundred and twenty-seven patent family members in forty countries.

The generic ingredient in VIBERZI is eluxadoline. One supplier is listed for this compound. Additional details are available on the eluxadoline profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Allergan Holdings drug VIBERZI
    Online Certificate Course

    Decision-Making for Generic Drug Entry & Branded Drug Lifecycle Management

    • When will key drug patents expire?
    • How can I find, evaluate, and plan for generic market entry opportunities?
    • How can I find proprietary out-of-court settlements and deal terms?
    DrugPatentWatch - Make Better Decisions